CG
ANAB icon

Cutler Group’s AnaptysBio ANAB Stock Holding History

Cutler Group’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,000
Closed -$16K – 3747
2023
Q2 		$16K Buy
+3,000
New +$60.8K ﹤0.01% 1957
2020
Q2 		– Sell
-5,000
Closed -$1K – 4326
2020
Q1 		$1K Sell
5,000
-9,700
-66% -$147K ﹤0.01% 3633
2019
Q4 		$72K Buy
14,700
+800
+6% +$18.9K ﹤0.01% 1383
2019
Q3 		$280K Buy
13,900
+13,700
+6,850% +$652K 0.03% 555
2019
Q2 		$2K Sell
200
-10,200
-98% -$734K ﹤0.01% 3499
2019
Q1 		$179K Sell
10,400
-2,700
-21% -$186K 0.02% 697
2018
Q4 		$364K Buy
13,100
+6,700
+105% +$498K 0.03% 420
2018
Q3 		$9K Buy
6,400
+1,400
+28% +$116K ﹤0.01% 2700
2018
Q2 		$82K Sell
5,000
-5,200
-51% -$436K 0.01% 1284
2018
Q1 		$10K Buy
10,200
+200
+2% +$22.5K ﹤0.01% 2775
2017
Q4 		$45K Buy
+10,000
New +$736K ﹤0.01% 1945

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Cutler Group's ANAB Position: Q3 2023 in Review

Cutler Group sold out of AnaptysBio (ANAB) in Q3 2023, closing a stake of 1,500 shares — an estimated $30K sold.

Cutler Group first reported a position in ANAB in Q4 2017 and held it in 16 quarters. The position peaked at $759K in Q4 2018. 116 funds tracked by Wall St. Rank hold ANAB as of Q3 2023.

  • Cutler Group reported no remaining AnaptysBio position as of Q3 2023 after selling out during the quarter.
  • Cutler Group sold 1,500 AnaptysBio shares in Q3 2023, an estimated $30K.
  • Cutler Group first reported a position in AnaptysBio in Q4 2017 and held it in 16 quarters.
  • Cutler Group's AnaptysBio position peaked at $759K in Q4 2018.
  • 116 funds tracked by Wall St. Rank held AnaptysBio as of Q3 2023.

Based on Cutler Group's 13F filing for Q3 2023, filed 7 Nov 2023.